Key facts
- This page summarizes Jane A. Harness's Form 4 filing for Innovation Pharmaceuticals Inc..
- 7 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 28 Sep 2022, 12:06.
Jane A. Harness - 01 Sep 2017 Form 4 Insider Report for Innovation Pharmaceuticals Inc.
- Reporting relationship
- Vice President
- Issuer ticker
- N/A
- Reported as of
- 01 Sep 2017
- Net transaction value
- $0
- Reporting owner signature
- /s/ Jane A. Harness
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Jane A. Harness filed Form 4 for Innovation Pharmaceuticals Inc. on 28 Sep 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IPIX
transaction
Class A Common Stock
Tax liability
- Transaction value
- $0
- Shares
- -1,000
- Change %
- -0.67%
- Price
- $0.000000
- Shares after
- 149,235
- Date
- 01 Sep 2017
- Ownership
- Direct
- Footnotes
- F1
IPIX
transaction
Class A Common Stock
Award
- Transaction value
- $0
- Shares
- +58,394
- Change %
- +39%
- Price
- $0.000000
- Shares after
- 207,629
- Date
- 01 Sep 2019
- Ownership
- Direct
- Footnotes
- F2
IPIX
transaction
Class A Common Stock
Tax liability
- Transaction value
- $0
- Shares
- -21,606
- Change %
- -10%
- Price
- $0.000000
- Shares after
- 186,023
- Date
- 11 Sep 2020
- Ownership
- Direct
- Footnotes
- F1
IPIX
transaction
Class A Common Stock
Award
- Transaction value
- $0
- Shares
- +58,394
- Change %
- +31%
- Price
- $0.000000
- Shares after
- 244,417
- Date
- 11 Sep 2020
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IPIX
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +172,987
- Change %
- Price
- $0.000000
- Shares after
- 172,987
- Date
- 01 Sep 2019
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 172,987
- Exercise price
- $0.1300
- Footnotes
- F3
IPIX
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +172,987
- Change %
- Price
- $0.000000
- Shares after
- 172,987
- Date
- 11 Sep 2020
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 172,987
- Exercise price
- $0.2200
- Footnotes
- F3
IPIX
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +500,000
- Change %
- Price
- $0.000000
- Shares after
- 500,000
- Date
- 10 Oct 2021
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 500,000
- Exercise price
- $0.2400
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents shares withheld for payment of tax liability arising as a result of the partial settlement of restricted stock awards that vested.
Footnote F2
Represents restricted stock vesting in three equal annual installments commencing on the first anniversary of the grant date.
Footnote F3
The stock option vests in three equal annual installments commencing on the first anniversary of the grant date.